Quality controls for serology: an unfinished agenda
- PMID: 32286243
- DOI: 10.1515/cclm-2020-0304
Quality controls for serology: an unfinished agenda
Comment on
-
Does a change in quality control results influence the sensitivity of an anti-HCV test?Clin Chem Lab Med. 2020 Jul 28;58(8):1372-1380. doi: 10.1515/cclm-2020-0031. Clin Chem Lab Med. 2020. PMID: 32145056
References
-
- Skendzel LP, Carski T, Herrmann K, Kiefer DJ, Namamura R, Nutter C, et al. Evaluation of performance criteria for multiple component test products intended for the detection and quantification of Rubella IgG antibody, NCCLS Document 12. Wayne, PA: National Committee for Clinical Laboratory Standards, 1992.
-
- Valoup-Fellous C. Standardization of rubella immunoassays. J Clin Virol 2018;102;34–8.
-
- CLSI C24A3. Statistical quality control for quantitative measurement procedures. Wayne, PA: Clinical and Laboratory Standards Institute, 2006.
-
- Dimech W, Karakaltsas M, Vincini GA. Comparison of four methods of establishing control limits for monitoring quality controls in infectious disease serology testing. Clin Chem Lab Med 2018;56:1970–8.
-
- Dimech WJ, Vincini GA, Cabuang LM, Wieringa M. Does a change in quality control results influence the sensitivity of an anti-HCV test? Clin Chem Lab Med 2020;58:1372–80.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources